DIA Labs is transforming asthma care with AirSense, an affordable and comfortable wearable device designed for continuous, real-time monitoring. Backed by provincial-level funding, AirSense provides accurate lung function data that integrates seamlessly with smartphones, empowering patients to stay in control of their condition. Its advanced AI-driven insights help predict asthma flare-ups, offering timely interventions. Not only is AirSense improving daily asthma management, but it’s also providing precise, real-world data that will be invaluable for advancing clinical trials. DIA Labs is committed to delivering innovative, cost-effective solutions for better respiratory health.
Director
Chief Scientific Officer
Manager of Strategic Business Partnerships and Regulatory Affairs
Intellectual Property
Fundraising
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.
